About us
Deep expertise.
Technology built for complexity.
Our team brings together deep experience in complex, specialty therapeutics with a track record of building innovative technology built for the realities of healthcare.
Our mission
Glidepath closes the gap between advanced therapies and the patients who need them, giving providers and sponsors the visibility to move with urgency, together. Because science should limit life-changing therapies, not administrative complexity.
Our team
Andy Moye, PhD
CEO, Co-Founder
Esther Moon
COO, Co-Founder
Josh Dahms
Founding Engineer
Kathy Maclin
VP Clinical Business Development
Board
Nadav Shimoni, MD
Board Member
Omar Edward Njie, MD, MPH
Board Member
Our values
Our values
The patient is the point
We’re not the heroes of this story. The heroes are the patients and the people working to bring life-saving therapies to them. Everything we build supports that journey.
Operate with urgency
Advanced therapeutics can’t save lives until they reach patients. We operate with urgency, agility, and are fully employed to the mission.
Do the right thing
Pragmatism over politics, candor over comfort. Let an honest read of the facts guide the next move.
Earn trust with every action
Our credibility is hard-won and continually earned every day. Trust is the cornerstone of every relationship with customers, partners, and one another.
Be domain obsessed
We’re not a solution in search of a problem. We’ve lived this challenge and understand it better than anyone. We start with the problem itself and bring the best answer to it.